(Q34264120)

1 August 2017

1 reference

title

Physiological approaches to neuroprotection. boosting of protective autoimmunity (English)

1 reference

1 August 2017

Schwartz M

1

1 reference

1 August 2017

publication date

1 May 2001

1 reference

1 August 2017

published in

Survey of Ophthalmology

1 reference

1 August 2017

volume

45 Suppl 3

1 reference

1 August 2017

page(s)

S256-60; discussion S273-6

1 reference

Autoimmune maintenance and neuroprotection of the central nervous system

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Neuroprotective effects of group III mGluR in traumatic neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Autoimmune T cells as potential neuroprotective therapy for spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Differential T cell response in central and peripheral nerve injury: connection with immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Autoimmunity can benefit self-maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Innate and adaptive immune responses can be beneficial for CNS repair

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Potential neuroprotective therapy for glaucomatous optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

Self-Protective mechanism awakened by glutamate in retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900208-9

7 January 2021

10.1016/S0039-6257(01)00208-9

Identifiers

DOI

1 reference

1 August 2017

1 reference